Showing results (141-150 of 2,408) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|December 6, 2012
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in SwedenNiklas Bergvall, Magnus Tambour, Freddie Henriksson, et al.Journal of Medical Economics|February 1, 2013
Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysisElizabeth L Eby, Ping Wang, Bradley H Curtis, et al.Journal of Medical Economics|February 1, 2013
Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamoleMichelle Friedman, James Spalding, Smita Kothari, et al.Journal of Medical Economics|January 10, 2013
Economic consequences of sequencing biologics in rheumatoid arthritis: a systematic reviewSean D Sullivan, Rafael Alfonso-Cristancho, Josh Carlson, et al.Journal of Medical Economics|January 11, 2013
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 yearsMerriKay Oleen-Burkey, Anissa Cyhaniuk, Eric SwallowJournal of Medical Economics|December 12, 2012
Comparative effectiveness research in the United States: a progress reportSean D Sullivan, Josh J Carlson, Ryan N HansenJournal of Medical Economics|February 28, 2013
Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IRJay Lin, Wing Chow, Myoung S Kim, et al.Journal of Medical Economics|February 28, 2013
Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational studyG Hechmati, S Cure, A Gouépo, et al.Journal of Medical Economics|May 31, 2012
Direct medical costs associated with atopic diseases among young children in ThailandJarungchit Ngamphaiboon, Thitima Kongnakorn, Patrick Detzel, et al.Journal of Medical Economics|February 14, 2013
Outcomes associated with concordance of oral antidiabetic drug treatments to prescribing information in patients with type 2 diabetes mellitus and chronic kidney diseaseS Y Chen, Y C Lee, V Alas, et al.Pageof 241